An intensive multidisciplinary lifestyle management program that results in significant weight loss reduces steatosis and fibrosis in pediatric patients with nonalcoholic fatty liver disease, according to a new study from Belgium.
Secondary to increasing rates of obesity in children and adolescents, pediatric NAFLD is now the most common pediatric liver disease worldwide, according to investigator Sander Lefere, MD, PhD, a postdoctoral researcher in the Department of Gastroenterology and Hepatology at Ghent University, in Belgium.